openPR Logo
Press release

Organoids Market Witness Heightened Revenue of US$ 3,420.40 million by 2027 with Business Market Insights: Hubrecht Organoid Technology, Organoid Therapeutics, Definigen, 3Dnamics, Inc. Cellesce Ltd.

07-27-2021 09:37 AM CET | Health & Medicine

Press release from: The Insight Partners

Organoids Market

Organoids Market

The Organoids Market was valued at US$ 689.47 million in 2019 and it is projected to reach US$ 3,420.40 million by 2027; it is expected to grow at a CAGR of 22.1% from 2020 to 2027.

Organoids are tiny, self-organized three-dimensional tissue cultures that are derived from stem cells. Such cultures can be crafted to replicate much of the complexity of an organ, or to express selected aspects of it like producing only certain types of cells. Organoids grow from stem cells—cells that can divide indefinitely and produce different types of cells as part of their progeny. Organoids can range in size from less than the width of a hair to five millimeters.

Organoids are microscopic and self-organizing 3D structures, which are grown from stem cells in vitro. They review various structural and functional characteristics of their in vivo counterpart organs. This multipurpose technology has led to the development of several novel human cancer models. It is now possible to create indefinitely expanding organoids starting from the tumor tissue of individuals suffering from a range of carcinomas. Alternatively, CRISPR-based gene modification allows the engineering of organoid models of cancer by introducing any combination of cancer gene alterations to normal organoids. Tumor organoids, when combined with immune cells and fibroblasts, becomes a model for the cancer microenvironment enabling immune-oncology applications.

(**Note: The sample of this report is updated with COVID-19 impact analysis**)

To Know How COVID-19 Pandemic Will Impact Global Organoids Market | Get a Sample Copy of Report, Click Here:
https://www.theinsightpartners.com/sample/TIPRE00017616/?source=openpr-10411

Top Companies of Organoids Market:
• STEMCELL Technologies, Inc.
• Cellesce Ltd.
• Hubrecht Organoid Technology
• Definigen
• 3Dnamics, Inc.
• Organoid Therapeutics
• PeproTech, Inc.
• Thermo Fisher Scientific
• Corning Incorporated (Life Sciences)
• Merck KGgA

Organoids – Market Segmentation

By Type
• Stomach
• Intestine
• Liver
• Pancreas
• Lung
• Brain
• Kidney
• Others

By Application
• Developmental Biology
• Disease Pathology of Infectious Disease
• Regenerative Medicine
• Drug Toxicity and Efficacy Testing
• Drug Discovery and Personalized Medicine
• Others

By Source
• Pluripotent Stem Cells
• Organ-Specific Adult Stem Cells

The key questions answered in this report:
• What will be the market size and growth rate in the forecast year?
• What are the key factors driving the Global Organoids Market?
• What are the risks and challenges in front of the market?
• Who are the key vendors in the Global Organoids Market?
• What are the trending factors influencing the market shares?
• What are the key outcomes of Porter’s five forces model?
• Which are the global opportunities for expanding the Global Organoids Market?

Researchers of this report throw light on different terminologies. The competitive landscape section of the report covers the solution, products, services, and business overview. This Global Organoids Market research report covers several dynamic aspects such as drivers, restraints and challenging factors.

This research report represents a 360-degree overview of the competitive landscape of the Global Organoids Market. Furthermore, it offers massive data relating to recent trends, technological advancements, tools, and methodologies. The research report analyzes the Global Organoids Market in a detailed and concise manner for better insights into the businesses.

Purchase a copy of the report @
https://www.theinsightpartners.com/buy/TIPRE00017616/?source=openpr-10411

In this study, the years considered to estimate the market size of Organoids are as follows:
History Year: 2014-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027

Finally, the researchers throw light on different ways to discover the strengths, weaknesses, opportunities, and threats affecting the growth of the Global Organoids Market. The feasibility of the new report is also measured in this research report.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Organoids Market Witness Heightened Revenue of US$ 3,420.40 million by 2027 with Business Market Insights: Hubrecht Organoid Technology, Organoid Therapeutics, Definigen, 3Dnamics, Inc. Cellesce Ltd. here

News-ID: 2338003 • Views:

More Releases from The Insight Partners

Emerging Technologies Boost Global Antiblock Additive Market Demand
Emerging Technologies Boost Global Antiblock Additive Market Demand
The Insight Partners is proud to announce its latest publication, "Antiblock Additive Market - An In-depth Analysis of the Global Industry Trends, Growth Drivers, and Forecasts (2025-2031)". This comprehensive research report provides a detailed examination of the Antiblock Additive Market, highlighting its current landscape, growth potential, emerging technologies, and competitive environment. According to the report, the Antiblock Additive Market is expected to register a CAGR of 5% from 2025 to 2031,
Global Microbiological Testing of Water Market Poised for Strong Growth Through 2031
Global Microbiological Testing of Water Market Poised for Strong Growth Through …
New York, US - October 20, 2025 - The global microbiological testing of water market is moving towards a major transformation, guided by rising environmental consciousness, robust regulatory frameworks, and increased recognition of the dire need for clean, potable water across both industrial and residential sectors. Recent studies from Verified Market Research and Kings Research project strong, sustained growth for this sector through 2031, highlighting global efforts to mitigate waterborne
Top Emergency Medical Services (EMS) Companies Regional and Data Analysis to 2031
Top Emergency Medical Services (EMS) Companies Regional and Data Analysis to 203 …
Emergency Medical Services (EMS) is a coordinated system that provides urgent medical care to people experiencing acute illnesses or injuries. EMS responds to emergencies through trained personnel such as paramedics, emergency medical technicians (EMTs), and other healthcare professionals. They offer on-scene medical assessment, treatment, and stabilization, and transport patients to hospitals when necessary. EMS operates via ambulances, air transport, and communication systems to ensure rapid response. Their goal is to
Generic Drugs Market Global Industry Outlook, Capacity and Capital Expenditure Forecasts
Generic Drugs Market Global Industry Outlook, Capacity and Capital Expenditure F …
The Insight Partners adds "Generic Drugs Market Forecast to 2031 COVID-19 Impact and Global Analysis" to its store providing analysis of the current and future market competition in the market. Insightful review of the key industry drivers, opportunities, barriers and challenges. Each trend is independently researched to provide qualitative analysis of its implications. Download Sample PDF @ https://www.theinsightpartners.com/sample/TIPRE00003414?utm_source=OpenPR&utm_medium=10881 Key Players Analysis: Teva Pharmaceutical Industries Ltd Viatris Inc Dr. Reddy's Laboratories Ltd Novartis AG Sun Pharmaceutical Industries Ltd AbbVie

All 5 Releases


More Releases for Organoid

07-17-2025 | Health & Medicine
4Dcell
4Dcell Achieves 95% Organoid Reproducibility Breakthrough With Patented Anchorin …
4Dcell announced that its SmartSphero plates have achieved over 95% reproducibility in organoid size and shape, while reducing organoid loss during medium exchanges to below 12%, a significant improvement over the 86% loss seen in traditional unanchored systems. This breakthrough addresses a persistent challenge in pharmaceutical drug screening and safety testing, where inconsistent organoid cultures have often hindered data reliability. The company's patented Anchoring Point Technology (APT®) allows researchers to culture
Organoid Culture Medium Research:the global Organoid Culture Medium market size …
QY Research Inc. (Global Market Report Research Publisher) announces the release of 2025 latest report "Organoid Culture Medium- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031". Based on current situation and impact historical analysis (2020-2024) and forecast calculations (2025-2031), this report provides a comprehensive analysis of the global Wire Drawing Dies market, including market size, share, demand, industry development status, and forecasts for the next few years.
Organoid Technology Market Size, Growth, In-depth Analysis, Research Report Fore …
The organoid technology market is estimated to grow at a CAGR of 27.12% during the forecast period. The prime factors propelling the growth of the organoid technology market are increasing demand for personalized medicine, drug discovery and development, and regenerative medicine. As per the report, the organoid technology market is expected to grow rapidly during the forecast period. Organoids are three-dimensional cell cultures that mimic the structure and function of human organs, making
Organoid Technology Market Trends, Future Demands, Growth Factors, Emerging Tech …
The global Organoids and Spheroids Market size was valued at $516.6 million in 2021 and is projected to reach $1.2 billion by 2031, growing at a CAGR of 8.5% from 2022 to 2031. Organoid technology bridges the gap between conventional two-dimensional cell line culture and in vivo models. The near-physiological technology can virtually recapitulates organ development and human diseases, such as infectious diseases, genetic abnormality and even cancers. Between traditional two-dimensional cell
Organoids Market Driven By Definigen, Organoid Therapeutics, Hubrecht Organoid T …
The scope of the organoids market includes type, application, source, and region. The organoids market is analyzed based on regions, such as North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America. The report offers insights and in-depth analysis of the organoids market emphasizing on various parameters, such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players across the globe.
Cancer Tumor Organoid Modifying the Overall Cancer Market Scenario
Within no time, the organoid cultures for cancer treatment have emerged as one of the most powerful modeling system in the field of cancer biology. From the very beginning of the market, it has been experiencing high adoption rate among the researchers and patients, minimum side effects and maximum appreciation for being unique among all the other 2-D model systems available in the market. The arrival of cancer organoids by